id	sid	tid	token	lemma	pos
work_mgh43svcqvd4fauljpsnjw2dlq	1	1	LETTER	LETTER	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	2	TO	to	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	3	THE	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	1	4	EDITORS	EDITORS	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	5	Rebuttal	Rebuttal	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	6	to	to	TO
work_mgh43svcqvd4fauljpsnjw2dlq	1	7	“	"	``
work_mgh43svcqvd4fauljpsnjw2dlq	1	8	ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	9	treatment	treatment	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	10	should	should	MD
work_mgh43svcqvd4fauljpsnjw2dlq	1	11	be	be	VB
work_mgh43svcqvd4fauljpsnjw2dlq	1	12	considered	consider	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	1	13	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	14	patients	patient	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	1	15	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	16	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	17	”	"	''
work_mgh43svcqvd4fauljpsnjw2dlq	1	18	Elif	Elif	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	19	Erkan	Erkan	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	20	Received	receive	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	1	21	:	:	:
work_mgh43svcqvd4fauljpsnjw2dlq	1	22	14	14	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	23	April	April	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	24	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	25	/Revised	/revised	SYM
work_mgh43svcqvd4fauljpsnjw2dlq	1	26	:	:	:
work_mgh43svcqvd4fauljpsnjw2dlq	1	27	25	25	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	28	April	April	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	29	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	30	/Accepted	/accepte	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	1	31	:	:	:
work_mgh43svcqvd4fauljpsnjw2dlq	1	32	29	29	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	33	April	April	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	34	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	35	/Published	/published	SYM
work_mgh43svcqvd4fauljpsnjw2dlq	1	36	online	online	RB
work_mgh43svcqvd4fauljpsnjw2dlq	1	37	:	:	:
work_mgh43svcqvd4fauljpsnjw2dlq	1	38	17	17	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	39	May	May	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	40	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	41	#	#	$
work_mgh43svcqvd4fauljpsnjw2dlq	1	42	IPNA	IPNA	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	1	43	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	1	44	We	-PRON-	PRP
work_mgh43svcqvd4fauljpsnjw2dlq	1	45	have	have	VBP
work_mgh43svcqvd4fauljpsnjw2dlq	1	46	presented	present	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	1	47	an	an	DT
work_mgh43svcqvd4fauljpsnjw2dlq	1	48	adolescent	adolescent	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	49	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	50	Amish	amish	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	1	51	descent	descent	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	52	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	53	atherosclerotic	atherosclerotic	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	1	54	renal	renal	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	1	55	artery	artery	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	56	stenosis	stenosis	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	57	as	as	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	58	a	a	DT
work_mgh43svcqvd4fauljpsnjw2dlq	1	59	cause	cause	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	60	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	1	61	hyperten-	hyperten-	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	1	62	sion	sion	NN
work_mgh43svcqvd4fauljpsnjw2dlq	1	63	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	2	1	He	-PRON-	PRP
work_mgh43svcqvd4fauljpsnjw2dlq	2	2	was	be	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	2	3	subsequently	subsequently	RB
work_mgh43svcqvd4fauljpsnjw2dlq	2	4	diagnosed	diagnose	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	2	5	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	2	6	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	2	7	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	2	8	a	a	DT
work_mgh43svcqvd4fauljpsnjw2dlq	2	9	rare	rare	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	2	10	autosomal	autosomal	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	2	11	recessive	recessive	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	2	12	genetic	genetic	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	2	13	disorder	disorder	NN
work_mgh43svcqvd4fauljpsnjw2dlq	2	14	characterized	characterize	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	2	15	by	by	IN
work_mgh43svcqvd4fauljpsnjw2dlq	2	16	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	2	17	retention	retention	NN
work_mgh43svcqvd4fauljpsnjw2dlq	2	18	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	2	19	both	both	CC
work_mgh43svcqvd4fauljpsnjw2dlq	2	20	plant	plant	NN
work_mgh43svcqvd4fauljpsnjw2dlq	2	21	sterols	sterol	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	2	22	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	2	23	cholesterol	cholesterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	2	24	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	2	25	affected	affect	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	2	26	individuals	individual	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	2	27	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	3	1	Determination	determination	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	2	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	3	3	his	-PRON-	PRP$
work_mgh43svcqvd4fauljpsnjw2dlq	3	4	serum	serum	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	5	sterol	sterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	6	profile	profile	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	7	by	by	IN
work_mgh43svcqvd4fauljpsnjw2dlq	3	8	gas	gas	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	9	chromatography	chromatography	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	10	revealed	reveal	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	3	11	91.2	91.2	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	12	%	%	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	13	cholesterol	cholesterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	14	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	3	15	normal	normal	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	3	16	>	>	XX
work_mgh43svcqvd4fauljpsnjw2dlq	3	17	99	99	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	18	%	%	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	19	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	3	20	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	3	21	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	3	22	elevated	elevated	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	3	23	plant	plant	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	24	sterol	sterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	25	levels	level	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	3	26	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	3	27	normal	normal	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	3	28	<	<	XX
work_mgh43svcqvd4fauljpsnjw2dlq	3	29	1	1	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	30	%	%	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	31	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	3	32	at	at	IN
work_mgh43svcqvd4fauljpsnjw2dlq	3	33	2.7	2.7	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	34	%	%	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	35	campesterol	campesterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	36	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	3	37	5.6	5.6	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	38	%	%	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	39	beta	beta	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	40	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	3	41	sitosterol	sitosterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	42	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	3	43	0.5	0.5	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	44	%	%	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	45	stigmasterol	stigmasterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	46	;	;	:
work_mgh43svcqvd4fauljpsnjw2dlq	3	47	these	these	DT
work_mgh43svcqvd4fauljpsnjw2dlq	3	48	findings	finding	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	3	49	were	be	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	3	50	consistent	consistent	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	3	51	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	3	52	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	3	53	[	[	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	3	54	1	1	CD
work_mgh43svcqvd4fauljpsnjw2dlq	3	55	]	]	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	3	56	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	4	1	His	-PRON-	PRP$
work_mgh43svcqvd4fauljpsnjw2dlq	4	2	genetic	genetic	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	4	3	testing	testing	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	4	has	have	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	4	5	not	not	RB
work_mgh43svcqvd4fauljpsnjw2dlq	4	6	yet	yet	RB
work_mgh43svcqvd4fauljpsnjw2dlq	4	7	been	be	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	4	8	completed	complete	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	4	9	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	4	10	but	but	CC
work_mgh43svcqvd4fauljpsnjw2dlq	4	11	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	4	12	clinical	clinical	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	4	13	picture	picture	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	14	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	4	15	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	4	16	patient	patient	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	17	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	4	18	elevated	elevated	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	4	19	serum	serum	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	20	plant	plant	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	21	sterols	sterol	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	4	22	support	support	VBP
work_mgh43svcqvd4fauljpsnjw2dlq	4	23	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	4	24	diagnosis	diagnosis	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	25	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	4	26	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	4	27	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	5	1	The	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	5	2	patient	patient	NN
work_mgh43svcqvd4fauljpsnjw2dlq	5	3	was	be	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	5	4	initially	initially	RB
work_mgh43svcqvd4fauljpsnjw2dlq	5	5	placed	place	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	5	6	on	on	IN
work_mgh43svcqvd4fauljpsnjw2dlq	5	7	atorvastatin	atorvastatin	NN
work_mgh43svcqvd4fauljpsnjw2dlq	5	8	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	6	1	After	after	IN
work_mgh43svcqvd4fauljpsnjw2dlq	6	2	he	-PRON-	PRP
work_mgh43svcqvd4fauljpsnjw2dlq	6	3	was	be	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	6	4	diagnosed	diagnose	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	6	5	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	6	6	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	6	7	he	-PRON-	PRP
work_mgh43svcqvd4fauljpsnjw2dlq	6	8	was	be	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	6	9	started	start	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	6	10	on	on	IN
work_mgh43svcqvd4fauljpsnjw2dlq	6	11	ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	6	12	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	6	13	resin	resin	NN
work_mgh43svcqvd4fauljpsnjw2dlq	6	14	colestid	colestid	NN
work_mgh43svcqvd4fauljpsnjw2dlq	6	15	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	7	1	We	-PRON-	PRP
work_mgh43svcqvd4fauljpsnjw2dlq	7	2	agree	agree	VBP
work_mgh43svcqvd4fauljpsnjw2dlq	7	3	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	7	4	Hu	Hu	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	7	5	et	et	FW
work_mgh43svcqvd4fauljpsnjw2dlq	7	6	al	al	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	7	7	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	8	1	that	that	DT
work_mgh43svcqvd4fauljpsnjw2dlq	8	2	ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	8	3	is	be	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	8	4	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	8	5	drug	drug	NN
work_mgh43svcqvd4fauljpsnjw2dlq	8	6	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	8	7	choice	choice	NN
work_mgh43svcqvd4fauljpsnjw2dlq	8	8	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	8	9	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	8	10	[	[	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	8	11	2	2	CD
work_mgh43svcqvd4fauljpsnjw2dlq	8	12	]	]	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	8	13	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	9	1	Ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	9	2	binds	bind	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	9	3	directly	directly	RB
work_mgh43svcqvd4fauljpsnjw2dlq	9	4	to	to	IN
work_mgh43svcqvd4fauljpsnjw2dlq	9	5	Niemen	Niemen	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	9	6	Pick	Pick	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	9	7	C1-like	C1-like	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	9	8	1	1	CD
work_mgh43svcqvd4fauljpsnjw2dlq	9	9	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	9	10	NPC1L1	NPC1L1	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	9	11	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	9	12	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	9	13	inhibits	inhibit	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	9	14	absorption	absorption	NN
work_mgh43svcqvd4fauljpsnjw2dlq	9	15	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	9	16	sitosterols	sitosterol	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	9	17	from	from	IN
work_mgh43svcqvd4fauljpsnjw2dlq	9	18	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	9	19	intestinal	intestinal	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	9	20	epithelium	epithelium	NN
work_mgh43svcqvd4fauljpsnjw2dlq	9	21	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	10	1	In	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	10	2	a	a	DT
work_mgh43svcqvd4fauljpsnjw2dlq	10	3	multicenter	multicenter	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	10	4	study	study	NN
work_mgh43svcqvd4fauljpsnjw2dlq	10	5	37	37	CD
work_mgh43svcqvd4fauljpsnjw2dlq	10	6	patients	patient	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	10	7	were	be	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	10	8	randomized	randomize	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	10	9	to	to	TO
work_mgh43svcqvd4fauljpsnjw2dlq	10	10	receive	receive	VB
work_mgh43svcqvd4fauljpsnjw2dlq	10	11	placebo	placebo	NN
work_mgh43svcqvd4fauljpsnjw2dlq	10	12	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	10	13	n=10	n=10	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	10	14	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	10	15	versus	versus	IN
work_mgh43svcqvd4fauljpsnjw2dlq	10	16	ezetimibe	ezetimibe	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	10	17	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	10	18	n=30	n=30	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	10	19	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	10	20	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	10	21	8	8	CD
work_mgh43svcqvd4fauljpsnjw2dlq	10	22	weeks	week	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	10	23	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	11	1	Ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	11	2	treatment	treatment	NN
work_mgh43svcqvd4fauljpsnjw2dlq	11	3	resulted	result	VBD
work_mgh43svcqvd4fauljpsnjw2dlq	11	4	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	11	5	a	a	DT
work_mgh43svcqvd4fauljpsnjw2dlq	11	6	significant	significant	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	11	7	reduction	reduction	NN
work_mgh43svcqvd4fauljpsnjw2dlq	11	8	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	11	9	sitosterol	sitosterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	11	10	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	11	11	campesterol	campesterol	NN
work_mgh43svcqvd4fauljpsnjw2dlq	11	12	levels	level	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	11	13	[	[	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	11	14	3	3	CD
work_mgh43svcqvd4fauljpsnjw2dlq	11	15	]	]	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	11	16	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	12	1	We	-PRON-	PRP
work_mgh43svcqvd4fauljpsnjw2dlq	12	2	believe	believe	VBP
work_mgh43svcqvd4fauljpsnjw2dlq	12	3	a	a	DT
work_mgh43svcqvd4fauljpsnjw2dlq	12	4	multidrug	multidrug	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	12	5	approach	approach	NN
work_mgh43svcqvd4fauljpsnjw2dlq	12	6	is	be	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	12	7	warranted	warrant	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	12	8	to	to	TO
work_mgh43svcqvd4fauljpsnjw2dlq	12	9	treat	treat	VB
work_mgh43svcqvd4fauljpsnjw2dlq	12	10	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	12	11	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	12	12	order	order	NN
work_mgh43svcqvd4fauljpsnjw2dlq	12	13	to	to	TO
work_mgh43svcqvd4fauljpsnjw2dlq	12	14	prevent	prevent	VB
work_mgh43svcqvd4fauljpsnjw2dlq	12	15	premature	premature	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	12	16	atherosclerotic	atherosclerotic	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	12	17	cardiovascular	cardiovascular	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	12	18	disease	disease	NN
work_mgh43svcqvd4fauljpsnjw2dlq	12	19	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	13	1	Although	although	IN
work_mgh43svcqvd4fauljpsnjw2dlq	13	2	there	there	EX
work_mgh43svcqvd4fauljpsnjw2dlq	13	3	is	be	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	13	4	no	no	DT
work_mgh43svcqvd4fauljpsnjw2dlq	13	5	doubt	doubt	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	6	that	that	IN
work_mgh43svcqvd4fauljpsnjw2dlq	13	7	ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	8	is	be	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	13	9	beneficial	beneficial	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	13	10	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	13	11	patients	patient	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	13	12	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	13	13	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	14	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	13	15	close	close	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	13	16	monitoring	monitoring	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	17	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	13	18	future	future	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	13	19	side	side	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	20	effects	effect	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	13	21	is	be	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	13	22	warranted	warrant	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	13	23	particularly	particularly	RB
work_mgh43svcqvd4fauljpsnjw2dlq	13	24	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	13	25	children	child	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	13	26	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	13	27	considering	consider	VBG
work_mgh43svcqvd4fauljpsnjw2dlq	13	28	their	-PRON-	PRP$
work_mgh43svcqvd4fauljpsnjw2dlq	13	29	longer	long	JJR
work_mgh43svcqvd4fauljpsnjw2dlq	13	30	life	life	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	31	span	span	NN
work_mgh43svcqvd4fauljpsnjw2dlq	13	32	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	14	1	References	reference	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	14	2	1	1	CD
work_mgh43svcqvd4fauljpsnjw2dlq	14	3	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	15	1	Webb	Webb	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	2	TN	TN	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	3	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	15	4	Ramratnam	Ramratnam	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	5	M	M	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	6	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	15	7	Pacella	Pacella	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	8	J	J	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	9	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	15	10	Erkan	Erkan	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	15	11	E	e	NN
work_mgh43svcqvd4fauljpsnjw2dlq	15	12	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	15	13	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	15	14	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	15	15	Atherosclerotic	atherosclerotic	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	15	16	renal	renal	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	15	17	artery	artery	NN
work_mgh43svcqvd4fauljpsnjw2dlq	15	18	stenosis	stenosis	NN
work_mgh43svcqvd4fauljpsnjw2dlq	15	19	as	as	IN
work_mgh43svcqvd4fauljpsnjw2dlq	15	20	a	a	DT
work_mgh43svcqvd4fauljpsnjw2dlq	15	21	cause	cause	NN
work_mgh43svcqvd4fauljpsnjw2dlq	15	22	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	15	23	hypertension	hypertension	NN
work_mgh43svcqvd4fauljpsnjw2dlq	15	24	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	15	25	an	an	DT
work_mgh43svcqvd4fauljpsnjw2dlq	15	26	adolescent	adolescent	JJ
work_mgh43svcqvd4fauljpsnjw2dlq	15	27	patient	patient	NN
work_mgh43svcqvd4fauljpsnjw2dlq	15	28	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	16	1	Pediatr	Pediatr	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	16	2	Nephrol	Nephrol	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	16	3	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	17	1	doi:10.1007	doi:10.1007	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	17	2	/	/	SYM
work_mgh43svcqvd4fauljpsnjw2dlq	17	3	s00467	s00467	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	17	4	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	17	5	014	014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	17	6	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	17	7	2774-y	2774-y	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	17	8	2	2	CD
work_mgh43svcqvd4fauljpsnjw2dlq	17	9	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	18	1	Hu	Hu	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	18	2	M	M	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	18	3	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	18	4	Tomlinson	Tomlinson	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	18	5	B	B	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	18	6	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	18	7	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	18	8	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	18	9	Ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	18	10	treatment	treatment	NN
work_mgh43svcqvd4fauljpsnjw2dlq	18	11	should	should	MD
work_mgh43svcqvd4fauljpsnjw2dlq	18	12	be	be	VB
work_mgh43svcqvd4fauljpsnjw2dlq	18	13	considered	consider	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	18	14	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	18	15	patients	patient	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	18	16	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	18	17	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	18	18	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	19	1	Pediatr	Pediatr	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	19	2	Nephrol	Nephrol	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	19	3	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	20	1	doi:10.1007	doi:10.1007	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	20	2	/	/	SYM
work_mgh43svcqvd4fauljpsnjw2dlq	20	3	s00467-	s00467-	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	20	4	014	014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	20	5	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	20	6	2843	2843	CD
work_mgh43svcqvd4fauljpsnjw2dlq	20	7	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	20	8	2	2	CD
work_mgh43svcqvd4fauljpsnjw2dlq	20	9	3	3	CD
work_mgh43svcqvd4fauljpsnjw2dlq	20	10	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	21	1	Salen	Salen	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	2	G	G	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	3	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	4	von	von	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	5	Bergmann	Bergmann	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	6	K	K	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	7	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	8	Lutjohann	Lutjohann	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	9	D	D	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	10	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	11	Kwiterovich	Kwiterovich	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	12	P	P	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	13	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	14	Kane	Kane	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	15	J	J	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	16	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	17	Patel	Patel	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	18	SB	SB	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	19	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	20	Musliner	Musliner	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	21	T	T	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	22	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	23	Stein	Stein	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	24	P	P	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	25	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	26	Musser	Musser	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	27	B	B	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	28	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	21	29	and	and	CC
work_mgh43svcqvd4fauljpsnjw2dlq	21	30	the	the	DT
work_mgh43svcqvd4fauljpsnjw2dlq	21	31	Multicenter	Multicenter	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	32	Sitosterolemia	Sitosterolemia	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	33	Study	Study	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	34	Group	Group	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	21	35	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	21	36	2004	2004	CD
work_mgh43svcqvd4fauljpsnjw2dlq	21	37	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	21	38	Ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	21	39	effectively	effectively	RB
work_mgh43svcqvd4fauljpsnjw2dlq	21	40	reduces	reduce	VBZ
work_mgh43svcqvd4fauljpsnjw2dlq	21	41	plasma	plasma	NN
work_mgh43svcqvd4fauljpsnjw2dlq	21	42	plant	plant	NN
work_mgh43svcqvd4fauljpsnjw2dlq	21	43	sterols	sterol	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	21	44	in	in	IN
work_mgh43svcqvd4fauljpsnjw2dlq	21	45	patients	patient	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	21	46	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	21	47	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	21	48	.	.	.
work_mgh43svcqvd4fauljpsnjw2dlq	22	1	Circulation	circulation	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	2	109:966–971	109:966–971	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	3	E.	E.	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	4	Erkan	Erkan	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	5	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	22	6	*	*	NFP
work_mgh43svcqvd4fauljpsnjw2dlq	22	7	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	22	8	Pediatrics	Pediatrics	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	9	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	22	10	Division	Division	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	11	of	of	IN
work_mgh43svcqvd4fauljpsnjw2dlq	22	12	Nephrology	Nephrology	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	13	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	22	14	Cincinnati	Cincinnati	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	15	Children	Children	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	16	’s	’s	POS
work_mgh43svcqvd4fauljpsnjw2dlq	22	17	Hospital	Hospital	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	18	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	22	19	Cincinnati	Cincinnati	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	20	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	22	21	OH	oh	UH
work_mgh43svcqvd4fauljpsnjw2dlq	22	22	,	,	,
work_mgh43svcqvd4fauljpsnjw2dlq	22	23	USA	USA	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	24	e	e	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	25	-	-	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	26	mail	mail	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	27	:	:	:
work_mgh43svcqvd4fauljpsnjw2dlq	22	28	Elif.Erkan@cchmc.org	elif.erkan@cchmc.org	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	29	Pediatr	Pediatr	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	30	Nephrol	Nephrol	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	31	(	(	-LRB-
work_mgh43svcqvd4fauljpsnjw2dlq	22	32	2014	2014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	33	)	)	-RRB-
work_mgh43svcqvd4fauljpsnjw2dlq	22	34	29:1471	29:1471	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	35	DOI	DOI	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	36	10.1007	10.1007	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	37	/	/	SYM
work_mgh43svcqvd4fauljpsnjw2dlq	22	38	s00467	s00467	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	39	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	22	40	014	014	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	41	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	22	42	2844	2844	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	43	-	-	HYPH
work_mgh43svcqvd4fauljpsnjw2dlq	22	44	1	1	CD
work_mgh43svcqvd4fauljpsnjw2dlq	22	45	http://dx.doi.org/10.1007/s00467-014-2774-y	http://dx.doi.org/10.1007/s00467-014-2774-y	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	46	http://dx.doi.org/10.1007/s00467-014-2843-2	http://dx.doi.org/10.1007/s00467-014-2843-2	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	47	http://dx.doi.org/10.1007/s00467-014-2843-2	http://dx.doi.org/10.1007/s00467-014-2843-2	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	48	Rebuttal	Rebuttal	NNP
work_mgh43svcqvd4fauljpsnjw2dlq	22	49	to	to	TO
work_mgh43svcqvd4fauljpsnjw2dlq	22	50	“	"	``
work_mgh43svcqvd4fauljpsnjw2dlq	22	51	ezetimibe	ezetimibe	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	52	treatment	treatment	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	53	should	should	MD
work_mgh43svcqvd4fauljpsnjw2dlq	22	54	be	be	VB
work_mgh43svcqvd4fauljpsnjw2dlq	22	55	considered	consider	VBN
work_mgh43svcqvd4fauljpsnjw2dlq	22	56	for	for	IN
work_mgh43svcqvd4fauljpsnjw2dlq	22	57	patients	patient	NNS
work_mgh43svcqvd4fauljpsnjw2dlq	22	58	with	with	IN
work_mgh43svcqvd4fauljpsnjw2dlq	22	59	sitosterolemia	sitosterolemia	NN
work_mgh43svcqvd4fauljpsnjw2dlq	22	60	”	"	''
work_mgh43svcqvd4fauljpsnjw2dlq	22	61	References	reference	NNS